ParkinSense Wins Santander X Global Award After International Finals

ParkinSense is proud to announce that it has won a Santander X Global Award, marking a major international milestone for the company.

The journey began at the Santander X UK Awards 2025, where ParkinSense came second in the University Category out of 800 applicants from across the UK. That result secured ParkinSense a place in the Santander X Global Awards, where the top ventures from Santander countries around the world competed on an international stage.

At the global competition, ParkinSense placed second and received a Santander X Global Award, an incredible accolade and a powerful moment of global recognition for the company's mission.

Founded by Adam Lockhart, ParkinSense is developing a non-invasive, AI-driven platform to support earlier detection of Parkinson's Disease. The platform is designed to help clinicians identify Parkinson's more quickly and accurately using structured digital assessments, machine learning and clear, data-backed insights.

This global recognition is an important step in ParkinSense's development, helping raise international awareness of the need for earlier Parkinson's detection and improved access to specialist insight.

As part of this achievement, ParkinSense is now part of Santander X 100, Santander's global community of high-potential companies. The community provides access to mentorship, networking, training, capital, talent and other resources designed to help outstanding ventures grow.

ParkinSense would like to thank Santander X, Santander UK, the judges, mentors and everyone who supported the company throughout both the UK and global competitions. This recognition strengthens ParkinSense's ambition to build a scalable digital health platform with meaningful clinical and global impact.